CCNA2 and psoriasis: Narrow-band UV-B (NBUVB), a commonly used means of treatment of psoriasis, could obviously reduction the expression of keratinocyte proliferation markers, Ki-67, cyclin A and cyclin B, to 62 %, 68 % and 81 %, respectively after NBUVB therapy [7].